Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets ; volume:17 ; number:1 ; day:2 ; month:9 ; year:2020 ; pages:1-15 ; date:12.2020
Journal of neuroinflammation ; 17, Heft 1 (2.9.2020), 1-15, 12.2020
- Creator
-
Govindarajan, Vaidya
de Rivero Vaccari, Juan Pablo
Keane, Robert W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-020-01944-9
- URN
-
urn:nbn:de:101:1-2020102322144319312360
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Govindarajan, Vaidya
- de Rivero Vaccari, Juan Pablo
- Keane, Robert W.
- SpringerLink (Online service)
Other Objects (12)
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
CD146: a potential therapeutic target for systemic sclerosis
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Luteolin as a therapeutic option for multiple sclerosis
erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Multiple sclerosis
Multiple sclerosis
Time to target brain atrophy and neurodegeneration in multiple sclerosis
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
CD146: a potential therapeutic target for systemic sclerosis
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Luteolin as a therapeutic option for multiple sclerosis
erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Multiple sclerosis
Multiple sclerosis
Time to target brain atrophy and neurodegeneration in multiple sclerosis
Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis
Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model
CD146: a potential therapeutic target for systemic sclerosis
Central nervous system intrinsic inflammation as driver and therapeutic target of progression in multiple sclerosis
Luteolin as a therapeutic option for multiple sclerosis
erratum “Current Evidence and Therapeutic Strategies for Multiple Sclerosis”
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact
Multiple sclerosis
Multiple sclerosis